Bildkälla: Stockfoto

Cantargia: Positive Results at ASCO 2022 - Redeye

Redeye has a favourable view of the topline results presented by Cantargia at ASCO 2022, which we discuss in this note.

Redeye has a favourable view of the topline results presented by Cantargia at ASCO 2022, which we discuss in this note.
Börsvärldens nyhetsbrev
ANNONSER